Dermatophytoma caused by terbinafine-resistant Trichophyton rubrum treated with fosravuconazole

J Dermatol. 2022 Nov;49(11):e407-e408. doi: 10.1111/1346-8138.16480. Epub 2022 May 31.

Authors

Hiromitsu Noguchi^{1

2}, Tadahiko Matsumoto^{1

2}, Masahide Kubo¹, Utako Kimura³, Masataro Hiruma², Takashi Yaguchi⁴, Tsuyoshi Yamada⁵, Rui Kano⁵

Affiliations

¹ Noguchi Dermatology Clinic, Kumamoto, Japan.
² Ochanomizu Institute for Medical Mycology and Allergology, Tokyo, Japan.
³ Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
⁴ Division of Bio-resources, Medical Mycology Research Center, Chiba University, Chiba, Japan.
⁵ Teikyo University Institute of Medical Mycology (TIMM), Tokyo, Japan.

PMID: 35638612
DOI: 10.1111/1346-8138.16480

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antifungal Agents / therapeutic use
Arthrodermataceae*
Humans
Microbial Sensitivity Tests
Terbinafine
Trichophyton

Substances

Terbinafine
Antifungal Agents

Supplementary concepts

Trichophyton rubrum